Straits Times Index
3,309.21 -12.87 (-0.39%) S&P 500
5,360.79 +13.80 (+0.26%) Dow
38,868.04 +69.05 (+0.18%) Nasdaq
17,192.53 +59.40 (+0.35%) Bitcoin USD
67,102.31 -2,261.82 (-3.26%) CMC Crypto 200
1,387.77 -53.86 (-3.74%)
KT&G Corporation (033780.KS)
| Previous close | 85,900.00 |
| Open | 86,000.00 |
| Bid | 86,300.00 x 0 |
| Ask | 86,400.00 x 0 |
| Day's range | 85,900.00 - 86,900.00 |
| 52-week range | 81,000.00 - 96,000.00 |
| Volume | |
| Avg. volume | 212,676 |
| Market cap | 9.759T |
| Beta (5Y monthly) | 0.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 10,200.00 (11.87%) |
| Ex-dividend date | 27 Dec 2023 |
| 1y target est | N/A |
- PR Newswire
KT&G opens 'Univ. Zone' at Tarumanagara University (UNTAR) for Indonesian college students
KT&G, a global company headquartered in South Korea, opened 'Univ. Zone', a community center for college students, at Tarumanagara University (UNTAR) on May 2, 2024.
- PR Newswire
KT&G Reports 2024 First Quarter Results; Robust Performances in Next Generation Product and Overseas Cigarette Sectors
KT&G Corporation ("KT&G" or the "Company") (KRX:033780), South Korea's leading tobacco manufacturer, today announced its financial results for the first quarter ended March 31, 2024. The company reported consolidated revenue of KRW 1.292 trillion and operating profit of KRW 236.6 billion.
- PR Newswire
Korea Ginseng Corporation Held a Dedicated International Seminar at the International Conference on the Science of Botanicals (ICSB) About Korean Red Ginseng in the United States
Korea Ginseng Corp. US (KGCUS) aka JungKwanJang held a dedicated international seminar session on "Korean Ginseng: Safety, Efficacy And Neuroprotective Insights'' at the International Conference on the Science of Botanicals (ICSB) hosted by the National Center for Natural Products Research (NCNPR). The conference is held annually at the Oxford Conference Center in Mississippi to bring together international leaders in the research, development, testing, regulation, and commercialization of botan
